CHA Publishes Resources to Support Hospitals’ Congressional Advocacy Efforts
What’s happening: CHA’s new federal resources can assist hospitals in their messaging to lawmakers on health policy options circulating in Washington, D.C. What else to know: The resources cover financial instability, rural hospital care, site-neutral policies, disproportionate share hospital payment cuts, and the 340B drug pricing program.
Congress Must Protect Patient Care
AHA Survey on 340B Rebate Model Closes Jan. 10
What’s happening: The American Hospital Association (AHA) is asking hospitals to complete a survey by Jan. 10 to help it understand how a 340B rebate model would impact 340B member hospitals.
What else to know: Completing this 10-question survey will help AHA understand the financial, operational, and patient impacts that a rebate model — such as the one Johnson & Johnson sought to implement this year — would have on your hospital or health system.
Urge Congress to Support Patient Care in Year-End Legislation
What’s happening: CHA issued an alert asking members to urge their congressional representatives to support hospital priority issues in year-end legislation.
What else to know: Outreach is needed by Dec. 20 when Congress will wrap up the session.
CHA Outlines Year-End Federal Legislative Health Care Priorities
What’s happening: In a Nov. 18 letter to the California congressional delegation, CHA outlined legislative priorities for the remainder of the 118th Congress — which must act by Dec. 20 to fund the federal government.
What else to know: It is likely that some health care extensions and policies could be a part of Congress’ funding package.
Johnson & Johnson Halts Proposed 340B Rebate Model
What’s happening: Johnson & Johnson will stop its plan that would have required hospitals participating in the 340B drug discount program to purchase Stelara and Xarelto at full price and apply for a rebate instead of receiving full discounts upfront.
What else to know: The Health Resources and Services Administration (HRSA) notified J&J it would be kicked out of the 340B Drug Pricing Program if it did not halt implementation.
Update on 2022 Outpatient PPS and Physician Fee Schedule Proposed Rules Participant Information
The Centers for Medicare & Medicaid Services (CMS) issued its calendar year (CY) 2022 outpatient prospective payment system (OPPS) proposed rule on July 19. CMS estimates that Medicare expenditures under OPPS will increase by $1.35 billion based on changes in the proposed rule. CMS also issued its calendar year (CY) 2022 physician fee schedule (PFS) proposed rule on July 13. CHA is hosting a members-only webinar to discuss updates to these proposed rules […]